Watch the Scancell Holdings webinar hosted by Vox Markets & Turner Pope Investments

09:02, 26th February 2021

Scancell Holdings (SCLP FOLLOW), the developer of novel immunotherapies for the treatment of cancer and infectious disease runs through their latest investor presentation and answers investor questions including those on their COVID vaccine candidate and expected milestones for 2021.

Disclaimer & Declaration of Interest

The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.

Login or register to post comments

Recent Articles